drugset / Trial / NCT02388321

Pediatric Ketamine Study for Pain Management

NCT02388321 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Direct comparison of intranasal sub-dissociative dose ketamine with intranasal fentanyl for the treatment of moderate to severe pain in pediatric patients in the emergency department.

Timeline

Start
2015-05-01
Primary completion
2016-12-31
Completion
2017-10-14

Outcome

Outcome not reported

Stopped: “Patients meeting inclusion criteria was low, and PI went to another institution.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified — Intranasal
Subject Ketamine Small molecule — Intranasal

Indications

No indication recorded.